Demonstrate the Value of Using Hypnosis in Chimiotherapy- Induced Chronic Neuropathies

Demonstrate the Value of Using Hypnosis in Chimiotherapy- Induced Chronic Neuropathies

Chimiotherapy produces neuropathies injuries to 30% to 70% cases. A third of those patients keeps suffering from this side effects disabilities and their quality of life is seriously affected.

Hypnosis, as a non-invasive tool without physical side effects, might be used to relieve them.

the purpose of this trial based on our own experience, is to demonstrate the value of using hypnosis and self-hypnosis in chimiotherapy- induced chronic neuropathies.

The aim will be to sustainably improve the quality of life by expanding self-management of pain and motor function side effect.

Inclusion Criteria:

• Minimum age :18 years
• Chemiotherapy- induced chronic neuropathies for at least 2 months with a DN4 score >4
• Failure of classic treatment used to relief neuropathic
• Having stopped chemotherapy treatment and being in complete or partial response or in tumoral stability
• Without any planed chemiotherapy during the study
• Having signed a written informed consent.
• French efficient understanding
• With health insurance coverage
• availability during all the study
• With efficient contraception for women of childbearing age

Exclusion Criteria:

• No participation to another study at the same time
• Suffering from neuropathy before having chemotherapy
• Other disease that may cause neuropathy
• deafness
• Any medicine that could cause neuropathy
• Neurological or psychiatrical disease past or present
• Mental retardation
• Allergy to EMG's electrodes
• Unable to consent, under tutelage or curatorship or judiciary safeguard
• Pregnant or nursing woman